Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, vol.136, pp.359-86, 2015. ,
A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy, Oncologist, vol.15, pp.699-731, 2010. ,
Prognostic and predictive biomarkers for epidermal growth factor receptor-targeted therapy in colorectal cancer: beyond KRAS mutations, Crit Rev Oncol Hematol, vol.85, pp.45-81, 2013. ,
RECIST: no longer the sharpest tool in the oncology clinical trials toolbox-point, Cancer Res, vol.72, pp.5145-5154, 2012. ,
Carcinoembryonic antigen in the staging and followup of patients with colorectal cancer, Cancer Invest, vol.23, pp.338-51, 2005. ,
Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: comparison to ctDNA and tissue in metastatic colorectal cancer, Oncotarget, vol.7, pp.85349-64, 2016. ,
Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types, Mol Oncol, vol.9, pp.783-90, 2015. ,
Circulating mutant DNA to assess tumor dynamics, Nat Med, vol.14, pp.985-90, 2008. ,
Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer, Mol Oncol, vol.8, pp.927-968, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-01076572
Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan, Clin Cancer Res, vol.18, pp.1177-85, 2012. ,
Prognostic value of circulating mutant DNA in unresectable metastatic colorectal cancer, Ann Surg, vol.251, pp.275-80, 2010. ,
Sensitive digital quantification of DNA methylation in clinical samples, Nat Biotechnol, vol.27, pp.858-63, 2009. ,
Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer, BMC Cancer, vol.13, p.566, 2013. ,
A study of hypermethylated circulating tumor DNA as a universal colorectal cancer biomarker, Clin Chem, vol.62, pp.1129-1168, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02295782
pyAmpli: an amplicon-based variant filter pipeline for targeted resequencing data, BMC Bioinformatics, vol.18, p.554, 2017. ,
Liquid biopsy"ectDNA detection with great potential and challenges, Ann Transl Med, vol.3, p.235, 2015. ,
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci Signal, vol.6, p.1, 2013. ,
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov, vol.2, pp.401-405, 2012. ,
Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA, PLoS One, vol.12, p.174308, 2017. ,
Detection of circulating tumor DNA in early-and late-stage human malignancies, Sci Transl Med, vol.6, pp.224-248, 2014. ,
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients, Nat Med, vol.21, p.827, 2015. ,
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer, Ann Oncol, vol.26, pp.1715-1737, 2015. ,
Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial, Lancet Oncol, vol.16, pp.937-985, 2015. ,
Analysis of circulating tumor DNA to monitor metastatic breast cancer, N Engl J Med, vol.368, pp.1199-209, 2013. ,
Early evaluation of circulating tumor DNA as marker of therapeutic efficacy in metastatic colorectal cancer patients (PLACOL study), Clin Cancer Res, vol.23, pp.5416-5441, 2017. ,
Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer, Int J Cancer, vol.140, pp.2134-2178, 2017. ,
Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer ,
Cell-free DNA in maternal plasma and serum: a comparison of quantity, quality and tissue origin using genomic and epigenomic approaches, Clin Biochem, vol.49, pp.1379-86, 2016. ,
Circulating deoxyribonucleic acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy, J Clin Oncol, vol.22, pp.4157-64, 2004. ,
Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer, Ann N Y Acad Sci, vol.1137, pp.98-107, 2008. ,
Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients, Clin Chem, vol.59, pp.1722-1753, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-02299581